Nuwellis, Inc. (NASDAQ:NUWE – Free Report) – Investment analysts at Roth Capital decreased their Q1 2025 earnings per share estimates for Nuwellis in a report issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now forecasts that the company will earn ($0.45) per share for the quarter, down from their previous estimate of ($0.30). The consensus estimate for Nuwellis’ current full-year earnings is ($8.17) per share. Roth Capital also issued estimates for Nuwellis’ Q2 2025 earnings at ($0.36) EPS, Q3 2025 earnings at ($0.35) EPS, Q4 2025 earnings at ($0.28) EPS, FY2025 earnings at ($1.39) EPS, FY2026 earnings at ($0.52) EPS, FY2027 earnings at $0.09 EPS, FY2028 earnings at $0.78 EPS and FY2029 earnings at $1.41 EPS.
Nuwellis Stock Performance
Shares of NUWE stock opened at $1.18 on Thursday. The stock’s fifty day moving average is $1.22 and its 200-day moving average is $1.34. The stock has a market capitalization of $5.16 million, a PE ratio of -0.01 and a beta of 0.36. Nuwellis has a 52 week low of $0.92 and a 52 week high of $17.15.
Hedge Funds Weigh In On Nuwellis
About Nuwellis
Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.
Further Reading
- Five stocks we like better than Nuwellis
- About the Markup Calculator
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What is the Euro STOXX 50 Index?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- What is the FTSE 100 index?
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.